Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer

Regulating Glucose Metabolism with Prodrug Nanoparticles for Promoting Photoimmunotherapy of Pancreatic Cancer

Abstract The low immunogenicity, insufficient infiltration of T lymphocytes, and dismal response to immune checkpoint blockade therapy pose major difficulties in immunotherapy of pancreatic cancer. Photoimmunotherapy by photodynamic therapy (PDT) can induce an antitumor immune response by triggering...

Full description

Bibliographic Details
Main Authors: Fang Sun, Qiurong Zhu, Tianliang Li, Madiha Saeed, Zhiai Xu, Feisheng Zhong, Rundi Song, Manxiu Huai, Mingyue Zheng, Cen Xie, Leiming Xu, Haijun Yu
Format: Article
Language:English
Published: Wiley 2021-02-01
Series:Advanced Science
Subjects:
glucose metabolism
immunogenic cell death
pancreatic cancer
photoimmunotherapy
prodrug nanoparticles
Online Access:https://doi.org/10.1002/advs.202002746

Internet

https://doi.org/10.1002/advs.202002746

Similar Items